Notch is related to the regulation of many cell life activities, such as cell death, cell proliferation and differentiation, and developmental fate switching. In stroke, Notch mediates neurogenesis, cell survival and death, inflammatory response, and oxidative stress. In view of the important role of Notch in the pathological process of stroke, targeting Notch to develop stroke drugs is an important way to treat stroke. Therefore, Ace Therapeutics provides comprehensive services to study the development of stroke drugs targeting Notch.
Notch regulates cell survival, death, proliferation, differentiation, and other processes through different signaling pathways. Therefore, it is an effective direction for stroke drug development to screen targets of related pathways by regulating Notch and then develop modulators with potential therapeutic activity against these targets. Ace Therapeutics provides comprehensive services to screen specific Notch-related targets in stroke pathology.
In view of the important regulatory role of Notch in various cellular activities, effective screening of appropriate modulators to regulate Notch activity is an important way to develop stroke drugs against candidate Notch pathway targets. Therefore, Ace Therapeutics has established different screening platforms for potential stroke drug candidates based on candidate Notch pathway targets.
The preclinical evaluation of drug candidates is an important step in drug development. For identified Notch modulators, Ace Therapeutics provides a well-developed service to examine their effects on stroke.
If you would like to learn more about our services, please feel free to contact us.
We are committed to accelerating progress in stroke research and drug development.